|
The document summarizes various studies on the biodegradation of perfluorinated compounds, specifically focusing on PFOS and N-EtFOSE, including their aerobic degradation in municipal wastewater treatment sludge.
|
— |
AR226-1030
|
re8oN7EZpLYqeZLK32k3GpY9V |
1 |
|
This is an aquatic toxicity worksheet documenting a 96-hour test on fathead minnows, including survival rates and water quality parameters, but lacks complete analytical details.
|
— |
AR226-1030
|
g2zQ5ppX3JDEeywLV7v6Yx2nV |
1 |
|
This is an aquatic toxicity worksheet detailing a 96-hour test on fathead minnows, including parameters such as survival rates and pH levels, with data recorded for various time intervals.
|
— |
AR226-1030
|
n9w0KdXyzLDD9Bqv05pkKxBQX |
1 |
|
This is a laboratory request form for water and wastewater analysis, detailing various parameters to be tested, including total hardness, pH, and total coliform, prepared for the Environmental Engineering Laboratory.
|
— |
AR226-1030
|
gD2kpkYqY49zVYQknzR3QJQKa |
1 |
|
This is a laboratory request form for ecological assessment testing, detailing various physical and chemical properties to be analyzed, but lacks specific analytical content.
|
— |
AR226-1030
|
0Ly87LM2zJqXEprgRekd4Q74J |
2 |
|
This is a worksheet from the Environmental Engineering Laboratory, likely related to sample analysis, but no specific analytical content is retained in the OCR.
|
— |
AR226-1030
|
aBNeb4ZDY1m7JjOoJM99Q3E69 |
3 |
|
This is a laboratory request form for water and wastewater analysis, detailing various parameters to be tested, including total hardness, pH, and total coliform, prepared for the Environmental Engineering Laboratory.
|
— |
AR226-1030
|
z6m4jnnQ3e6qgQa9ekEvD53z |
1 |
|
This is a notice from 3M regarding the submission of documents to the EPA related to fluorochemistry discussions, emphasizing that the documents are for read-only purposes and that paper copies are the controlling version in case of discrepancies.
|
— |
AR226-1030
|
6RbzxoBkjKMYwx7kaqevqpQgd |
1 |
|
This is a notice from 3M regarding the submission of documents to the EPA related to fluorochemistry, emphasizing that the documents are for read-only purposes and that original paper copies will be maintained for accuracy.
|
— |
AR226-1030
|
ppy5GQzRDazQEY0j0Ok1rJ4r6 |
1 |
|
The document is a solubility study of Perfluorooctanesulfonate (PFOS) and Perfluorooctanesulfonamide (FOSA) conducted by 3M Environmental Laboratory, detailing the methods and findings related to their solubility in human urine.
|
— |
AR226-1030
|
7MK5v7Y6LRx2KK9ZLVVXaQRNj |
175 |
|
The document reports on a 104-week dietary chronic toxicity study of Perfluorooctane Sulfonic Acid Potassium Salt (PFOS T-6295) in rats, conducted by 3M Environmental Laboratory, focusing on the determination of PFOS concentrations in liver and serum specimens.
|
— |
AR226-1051
|
dQgmB1686DybLBdJLQdDny9y6 |
181 |
|
This document is a notice from 3M regarding a compact disk containing information submitted to the EPA about fluorochemistry, intended for read-only access.
|
— |
AR226-1051
|
a11e7RX9B6gNbaV6QLE0jb5Xe |
1 |
|
The document is a solubility study of Perfluorooctanesulfonate (PFOS) and Perfluorooctanesulfonamide (FOSA) conducted by 3M Environmental Laboratory, detailing methods and findings related to their solubility in human urine.
|
— |
AR226-1030
|
4aZbz9gMKyOY70jqnRXpJad9V |
175 |
|
This document outlines a method for the determination of Perfluorooctane sulfonate (PFOS), Perfluorooctane Sulfonylamide (PFOSA), and Perfluorooctanoate (POAA) in water samples using liquid-solid extraction and high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS/MS).
|
— |
AR226-0190
|
Lp1qJ9MQmmjgr2gO35e16Oqpz |
17 |
|
The document contains a series of submissions by 3M to the EPA under TSCA 8(e) regarding various fluorochemicals, including perfluoroalkyl mixtures and N-ethyl perfluoro compounds, along with preliminary findings from ongoing teratology studies and responses to EPA inquiries about toxicity and employee exposure.
|
— |
AR226-0199
|
93pajD8gQddJ8VqGYyKVw9R6L |
17 |
|
This document is a report of an acute oral toxicity study conducted by Hazleton Laboratories America, Inc. on a sample (T-3607) for Minnesota Mining and Manufacturing, involving Sprague-Dawley rats administered a single dosage of 5.0 mg/kg body weight.
|
— |
AR226-0207
|
zdgy0xQL9Dz65oo2VkXEkDD36 |
6 |
|
This document outlines a study protocol by Argus Research Laboratories, sponsored by 3M Toxicology Services, to assess the reproductive toxicity of PFOS in rats, focusing on various stages of reproduction and potential effects on offspring development.
|
— |
AR226-0561
|
e5q0R5nZ7aNow070yx6XZrvRe |
68 |
|
Unreadable document.
|
— |
AR226-0213
|
ev2RdnMBaaGkbXpa4dvrzEabg |
7 |
|
The document outlines a pharmacokinetic study protocol by 3M to assess the oral absorption, clearance, and biological persistence of Perfluorooctane Sulfonamide (PFOSA) in rats, with a focus on determining its potential conversion to PFOS and analyzing metabolites using advanced analytical techniques.
|
— |
AR226-0214
|
9930Dn3byrm450Qd6aO9LbwNV |
10 |
|
The document is an amendment to a laboratory report from 3M Environmental Laboratory regarding the analysis of potassium perfluorooctanesulfonate (PFOS) in the serum and liver of Sprague-Dawley rats, correcting inaccuracies in the purity value of the analytical reference substance PFOS Lot 193 and noting that further chemical characterization is needed.
|
— |
AR226-0562
|
JNYMadv93My1193m5Xo5XjrBa |
4 |
|
The document is a final report from Hazleton Laboratories America, Inc. detailing a primary dermal irritation/corrosion study of the test substance T-4102, conducted on rabbits according to OECD guidelines.
|
— |
AR226-0231
|
rejBpg8303vew2kyG9vd63dMe |
9 |
|
The document is a final report from Hazleton Laboratories detailing an OECD eye irritation study conducted on rabbits using a test substance, identified as sample T-4102, for Minnesota Mining & Manufacturing.
|
— |
AR226-0230
|
kmZg42RoEoJ1e9rdGrVaYp4qb |
17 |
|
The document summarizes a biopersistence screening study conducted by DuPont on potassium perfluoroalkyl sulfonate (PFOS) in male rats, detailing the exposure periods, treatment methods, and the analysis of total fluorine content in blood samples collected post-dosing.
|
— |
AR226-0574
|
RavMVooBg6b94ZJBQm1e4JOBn |
53 |
|
The document provides a voluntary use and exposure information profile for Perfluorooctane sulfonamide (CAS Number 754-91-6), detailing 3M Company's synthesis process using Simons Electro-Chemical Fluorination and indicating no commercial activity for the substance.
|
— |
AR226-0577
|
mqjEd8LVQ2a3OE2D29pEDpB8B |
14 |
|
The document provides information on the chemical N-ethylperfluorooctylsulfonamido ethyl acrylate (EtFOSEA) produced by 3M Company using the Simons Electro-Chemical Fluorination process, detailing its synthesis and distribution.
|
— |
AR226-0584
|
8BG0b5NMOp3ppYXRXvRmmqXd |
19 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-0589
|
jBZGNpRdZpv2vEa3anvO6X1G2 |
1 |
|
This is a proposed agenda for a meeting organized by the American Chemistry Council regarding EPA's invitation to discuss concerns about PFOS and related compounds, scheduled for June 19, 2000.
|
— |
AR226-0591
|
vVpxN2JRMwmxVm8wd7op0nnm6 |
3 |
|
Unreadable document.
|
— |
AR226-0592
|
zokrb5bwObpmYw4ndrEvzqM7R |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-0601
|
9JnOKXV9LN3yQQXeQ9JOb0607 |
1 |
|
This document outlines the voluntary use and exposure information for Ammonium Perfluorooctanoate (APFO) by E. I. du Pont de Nemours and Company, detailing its role as a reaction aid in the production of polytetrafluoroethylene (PTFE) and the management of APFO waste at various sites.
|
— |
AR226-0599
|
DGz7QDZyry9D6DV7wnNV4zLYO |
11 |
|
Unreadable document.
|
— |
AR226-0603
|
NEZM47ab9Vb8N9ZGoXDXBQbQ8 |
1 |
|
Unreadable document.
|
— |
AR226-0607
|
xzy56KvGNVX8Mr64YQBvJBdLb |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-0608
|
yrLxQOkqz0xXkqO5qXe1neqjX |
1 |
|
Unreadable document.
|
— |
AR226-0613
|
M4GM1JnBJ032Q8KXVyOKM2yMM |
1 |
|
This study investigates the mechanism of toxicity of the pesticide ethylperfluorooctane sulfonamide (NEPFOS) and its metabolite perfluorooctane sulfonamide (PFOS) on isolated rabbit renal cortical mitochondria, finding that PFOS acts as a protonophore and uncouples oxidative phosphorylation, while NEPFOS requires metabolism to PFOS to exhibit cyt
|
— |
AR226-0240
|
DG70YkDvobdKaKy7xd6LnLedO |
1 |
|
This document reports on an exploratory 28-day oral toxicity study of telomer alcohol and telomer acrylate, including PFHS and PFOS as positive controls, conducted on rats to assess various health parameters and recovery effects.
|
— |
AR226-1030
|
8VoRV65eV0Z72zBY6Qn11DzMo |
742 |
|
The document outlines 3M's Environmental Program objectives and plans for assessing the environmental fate and effects of fluorochemicals, specifically focusing on PFOA and PFOS, including strategies for minimizing their release and characterizing associated risks.
|
— |
AR226-0627
|
2NQNQddrd2obY9gaK4B2MqdeL |
19 |
|
Unreadable document.
|
— |
AR226-0638
|
ymj5mYEYoKD9ke2O4Xjz58n34 |
1 |
|
The document is a final report from Hazleton Laboratories America, Inc. detailing a study on the primary dermal irritation of a test material (T-3752) on rabbits, conducted according to OECD guidelines, with the aim of assessing skin irritation potential.
|
— |
AR226-0243
|
Rpon1Z22zX5grgJEOYQ5nMDLv |
17 |
|
The document is a final report from Hazleton Laboratories America, Inc. detailing an OECD eye irritation study on a test substance identified as T-3752, which is a brown granular solid, conducted on young adult New Zealand White rabbits to assess ocular irritation.
|
— |
AR226-0244
|
0q58Q95eeQbDDr4q39J2awqKV |
22 |
|
This interim report from 3M Company details a study on the serum half-lives of PFOS and PFOA in retired fluorochemical production employees, indicating that the serum half-life of PFOS is likely four-fold lower than previously estimated, while PFOA's half-life appears to be approximately one year.
|
— |
AR226-0645
|
N2Ko7JgYYgBR26dEmqZemdRJp |
10 |
|
This internal correspondence from August 2000 discusses pooled human sera sample results for PFOS collected from European blood banks, indicating consistent findings with previous data, with average concentrations of PFOS measured in Belgium (17 ppb), the Netherlands (53 ppb), and Germany (37 ppb).
|
— |
AR226-0646
|
Ed6Om5ZNkYeJxVqQbbD744xk4 |
2 |
|
The document discusses the results of skin and eye irritation assessments conducted on FC-95 (T-1117), a product containing PFOS, by WARF Institute, indicating it is non-irritating to skin but minimally to mildly irritating to eyes, with recommendations for precautionary labeling.
|
— |
AR226-0647
|
Xg9BLp95p5EErY8QKdQXX46d |
8 |
|
The document is a final report from SRI International examining the mutagenic activity of 3M Company's Compound T-2816CoC, which was found to be non-mutagenic and non-recombinogenic in various in vitro assays involving Salmonella typhimurium and Saccharomyces cerevisiae.
|
— |
AR226-0648
|
pQegQK9J32Q2D6dY5Zr8oZ0j |
15 |
|
The document is a final report from SRI International assessing the mutagenic activity of 3M Company's Compound T-2997CoC (related to PFOS) using the Ames Salmonella/microsome assay and yeast assays, concluding that the compound was not mutagenic or recombinogenic in any tests performed.
|
— |
AR226-0649
|
JQKaLNjOymRqjLZOoL3y16yO |
18 |
|
The document is a draft electron microscopy report detailing the findings from a 26-week toxicity study of perfluorooctane sulfonic acid (PFOS) in cynomolgus monkeys, indicating that liver lesions observed during treatment have resolved in recovery animals.
|
— |
AR226-0650
|
Ed1n3boLdk69JK7E843wj212g |
35 |
|
This document reports on a 6-month study of PFOS conducted on cynomolgus monkeys, detailing various biochemical parameters such as TSH, cholesterol, HDL, LDL, and VLDL levels across different groups.
|
— |
AR226-0651
|
8VnvVzwerJRm4RK6jgRYz87y5 |
12 |
|
A 28-day percutaneous absorption study of FC-98, a perfluorinated compound, was conducted on albino rabbits at Riker Laboratories, revealing dermal absorption potential but inconclusive results due to limited sample analysis.
|
— |
AR226-0653
|
v1QKn49yvRBygmvqDM946ZDzY |
17 |
|
The document is a master's thesis by Deanna J. Nabbefeld that investigates the effects of perfluorooctane sulfonic acid (PFOS) and other fluorocarbons on liver fatty acid-binding protein (L-FABP), finding that PFOS significantly decreases the maximum binding capacity of L-FABP in treated rats.
|
— |
AR226-0652
|
qd4779nYDbL3x3LqK78nq92Vx |
56 |
|
This document is a final report on a single-dose intravenous pharmacokinetic study of T-6684, a compound related to PFOS, conducted by Corning Hazleton Inc. for 3M, with completion dated December 31, 1997.
|
— |
AR226-0654
|
4agjGEEbDLDvm4DpLzneraDEp |
37 |
|
The document is a final report from Covance Laboratories Inc. detailing a 5-daily dose dermal absorption/toxicity study of the substance T-6684, sponsored by 3M, conducted on rabbits, with a completion date of December 31, 1997.
|
— |
AR226-0655
|
jBe5nQ77XkKk47kENKVJ0Lqnp |
54 |
|
Unreadable document.
|
— |
AR226-0999
|
pprNrdwvY7YXnO3R4ND39ER3E |
1 |
|
Unreadable document.
|
— |
AR226-1002
|
yp3Gzqk5x01K185JRM3JmYQmV |
1 |
|
The document discusses the toxicological evaluation of APFO (Ammonium Perfluorooctanoate), highlighting its low to moderate toxicity, liver as the primary target organ, and findings from a multi-generation reproduction study in rats, indicating no significant reproductive effects at various dose levels.
|
— |
AR226-1011
|
nmRVMGpB9kqoV57vv0ZN7413a |
13 |
|
Unreadable document.
|
— |
AR226-1014
|
OEp0GdzD1Dj9L1Do5o3vdG2gj |
1 |
|
This document reports on an acute contact toxicity study of Perfluorooctanesulfonate (PFOS) conducted with honey bees, initiated by 3M Corporation and performed by the Central Science Laboratory, confirming compliance with Good Laboratory Practice regulations.
|
— |
AR226-1018
|
Jrz5Ok421JJky3MezaLmJ9BqO |
28 |
|
This document is a report amendment for an acute oral toxicity study of Perfluorooctanesulfonate, Potassium Salt (PFOS) conducted with honey bees, submitted to 3M Corporation, correcting typographical errors in the original report.
|
— |
AR226-1017
|
aXKg3y4wV92xJJ0Xoj6goE6N |
39 |
|
This document outlines a pharmacokinetic study of perfluorooctane sulfonyl fluoride (POSF) in male Sprague Dawley rats to assess its oral absorption, clearance, and metabolism to perfluorooctane sulfonate (PFOS) for risk characterization, conducted by 3M Chemicals Division.
|
— |
AR226-0656
|
7ORXMJEXNz04gwGOjk4DDq7Xe |
8 |
|
The document is a final report on a 13-week dietary toxicity study of N-Methyl Perfluorooctanesulfonamido Ethanol (N-MeFOSE, T-6314) conducted on rats, prepared for 3M by Covance Laboratories.
|
— |
AR226-0615
|
xzZE4J93bqZ0Q9EKyYoV5XyEQ |
561 |
|
The document reports on the evaluation of the mutagenic activity of T-6906 using an in vitro mammalian cell gene mutation test with L5178Y mouse lymphoma cells, conducted by NOTOX B.V. in compliance with Good Laboratory Practice standards.
|
— |
AR226-0253
|
KGGMGg6VRGo368dRJo0rrZZb0 |
31 |
|
The document is an amendment to a two-year oral toxicity/carcinogenicity study of fluorochemical FM-3924 in rats, clarifying that while the incidence of benign hepatic adenomas in high-dose females was outside historical limits, it was not statistically significant, and overall, FM-3924 was not considered carcinogenic under the study conditions.
|
— |
AR226-0262
|
7MeJm5OQKn6Q0DMN4kboLKVx8 |
4 |
|
The document reports on an acute oral toxicity study of the substance FM-3422, provided by 3M Company, which determined the LD50 values for male and female rats to be 1615 mg/kg and 1333 mg/kg, respectively.
|
— |
AR226-0657
|
2jgQaBo58d314ogZ2ynZ1LaN6 |
14 |
|
The document reports on a study conducted by Riker Laboratories, Inc. that identified a major metabolite of carbon-14 labeled N-ethyl FOSE in rats, specifically 2-N-ethyl perfluorooctanesulfonamido acetic acid (PFSAA), which accounted for at least 50% of the carbon-14 excreted in feces after administration of the
|
— |
AR226-0658
|
XOvz8opLyZrjp7LdOQneNbOjd |
22 |
|
The document is a final report of a pilot rat teratology study (Project No. 154-159) conducted by Hazleton Laboratories America, Inc. for 3M Company, focusing on the effects of N-Et FOSE alcohol on maternal and fetal outcomes.
|
— |
AR226-0659
|
YG6RoyKx2EJ2JbZMRMmbzNQjk |
51 |
|
The document outlines a rat teratology study protocol to assess the embryo/fetal toxicity and teratogenic potential of the test material T-3352, administered by gavage to pregnant rats during fetal organogenesis, in compliance with FDA guidelines.
|
— |
AR226-0661
|
0gv8p5OKx3dV5GRXn4DaZ8YOM |
14 |
|
The document reports on an acute oral toxicity study of the substance T-3067C conducted on albino rats, finding that the approximate oral LD50 is greater than 5,000 mg/kg with no observed adverse effects.
|
— |
AR226-0662
|
e7EZpn2ZmkyLJ35JgLO2L5yJm |
9 |
|
The document is a final report of a rat teratology study (Project No. 154-161) conducted by Hazleton Laboratories America, Inc. for 3M Company, focusing on the effects of N-Et FOSE alcohol, a perfluorinated compound, under Good Laboratory Practice regulations.
|
— |
AR226-0660
|
KJboqjVGGpNKOGBE68q5zjjew |
80 |
|
This document is a final report on a single-dose intravenous pharmacokinetic study of T-5904, a compound produced by 3M, conducted on rabbits by Hazleton Wisconsin, Inc., with a completion date of October 14, 1994.
|
— |
AR226-0663
|
QkG71ZyrY6KDzrjX3V6e0kM4E |
25 |
|
This document is a final report from Hazleton Laboratories detailing an acute oral toxicity study of PFOA (sample T-4416) conducted on rats, following OECD guidelines, with a focus on methodology and results.
|
— |
AR226-0665
|
rwx4nGkgMg6yNxyQ6wnRxLVq |
23 |
|
This document is a final report from Hazleton Laboratories detailing an acute toxicity study on PFOA (sample T-4416) conducted on rabbits to assess primary dermal irritation/corrosion according to OECD guidelines.
|
— |
AR226-0666
|
mBRx3JGGd1wv5880Rj38zVb4g |
10 |
|
This document is a final report from Hazleton Laboratories America detailing an acute toxicity study on PFOA (sample T-4416) assessing ocular irritation/corrosion in rabbits, conducted according to OECD guidelines.
|
— |
AR226-0667
|
gavrr1rXqwBKZQmmda5JeGpYe |
18 |
|
The document is a final report on a mutagenicity test conducted by Corning Hazleton on PFOA, measuring chromosomal aberrations in Chinese hamster ovary (CHO) cells, submitted to 3M, and completed on April 25, 1996, confirming compliance with Good Laboratory Practice regulations.
|
— |
AR226-0668
|
BN2o4L182a2mrmZy1OXgdL7o |
42 |
|
This document is a final report of a mutagenicity test on PFOA conducted by Corning Hazleton Inc. using an in vivo mouse micronucleus assay, submitted to 3M, and confirms compliance with Good Laboratory Practice regulations.
|
— |
AR226-0669
|
yrxOK2Ma3koxrjg0X444GmLQn |
37 |
|
The document is an analytical report from Centre Analytical Laboratories detailing the characterization of surface water samples collected in Mobile, Alabama, specifically analyzing for perfluorooctane sulfonate (PFOS), perfluorooctane sulfonamide (PFOSA), and perfluorooctanoate (POAA) using liquid chromatography/tandem mass spectrometry (LC/MS/MS).
|
— |
AR226-0673
|
2j7M0GGGNNjxQy8doxzROqOn7 |
8 |
|
This analytical report from Centre Analytical Laboratories details the characterization of surface water samples collected from Pensacola, FL, specifically analyzing for perfluorinated compounds including PFOS, PFOSA, and POAA using liquid chromatography/tandem mass spectrometry.
|
— |
AR226-0674
|
XRRRJvm1aD1a9VbMadQ1wJ1QJ |
8 |
|
This analytical report from Centre Analytical Laboratories details the characterization of surface water samples from Port St. Lucie, FL, specifically analyzing for perfluorinated compounds including PFOS, PFOSA, and POAA using liquid chromatography/tandem mass spectrometry.
|
— |
AR226-0675
|
3NkDQbpmDLEKwNxdb8wpk62X3 |
6 |
|
Chemguard Inc. submitted confidential information regarding their AFFF type foam concentrate, Chemguard FS-100, which contains a proprietary fluorochemical surfactant and has been used in all their AFFF agents since its introduction.
|
— |
AR226-1040
|
JNg3MEGZ7EnyVmR7kX5QYz8O2 |
1 |
|
The document details GC/MS analyses of various perfluorinated compounds, including N-Ethyl and N-Methyl carboxamides, with specific concentration percentages reported for each compound.
|
— |
AR226-0265
|
RpgRQX9zroL5mZQ4DMdyrRKav |
4 |
|
The document reviews a two-year oral toxicity and carcinogenicity study of fluorochemical FM-3924 conducted on rats, commissioned by 3M Corporate Toxicology, highlighting significant findings of hepatocellular adenomas and carcinomas in high-dose female rats, alongside notable reductions in body weight and liver weight increases in high-dose groups.
|
— |
AR226-0266
|
dD58rXEDXyYjnYrKm0R1wr46b |
2 |
|
This document outlines a study protocol by 3M to determine the serum elimination half-lives of perfluorooctanoate (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorohexanesulfonate (PFHxS) in retired employees from the Decatur Chemical Plant, with blood samples collected biannually over five years for
|
— |
AR226-0023
|
pm54aLzG7vZroV8mJjdBnajKX |
20 |
|
This document outlines a method for analyzing potassium perfluorooctanesulfonate (PFOS) and other fluorochemical surfactants in serum extracts using HPLC-electrospray/mass spectrometry, detailing the applicable compounds and matrices for testing.
|
— |
AR226-0025
|
dQg1YV128goy244VO0oBjq6G0 |
9 |
|
This document outlines a method (ETS-8-7.0) developed by 3M Environmental Laboratory for analyzing potassium perfluorooctanesulfonate (PFOS) and other fluorochemical surfactants in liver extracts using HPLC-electrospray/mass spectrometry.
|
— |
AR226-0027
|
71kaLX9KNMga8QbOEZ5DkLkw8 |
10 |
|
This document outlines a laboratory method (ETS-8-6.0) developed by 3M for the extraction of potassium perfluorooctanesulfonate (PFOS) and other fluorochemical compounds from liver tissues using HPLC-Electrospray/Mass Spectrometry.
|
— |
AR226-0026
|
50DQg3BExe6Z3vneq9V0pbQ54 |
14 |
|
The document outlines a method for analyzing potassium perfluorooctanesulfonate (PFOS) and other fluorochemical compounds in urine extracts using HPLC-electrospray/mass spectrometry, detailing the procedure and applicable matrices for testing.
|
— |
AR226-0029
|
V3yYy2VnGqQdNMzr5KBQvD11g |
9 |
|
This document outlines a laboratory method (ETS-8-96.0) for extracting potassium perfluorooctanesulfonate (PFOS) and other fluorochemical compounds from urine using HPLC-Electrospray/Mass Spectrometry, detailing the procedure and applicable matrices for analysis.
|
— |
AR226-0028
|
85wjkGxBBO17G4kren0xqqYLm |
14 |
|
This 3M technical report details the analysis of serum samples from Decatur employees, identifying the presence of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and perfluorohexanesulfonate (PFHxS), with PFOS being the most prevalent compound.
|
— |
AR226-0034
|
MJg4w56BDjgKYdzLLQkoGK7Gx |
4 |
|
This document reports on a serum fluorochemical assessment of 94 Sumitomo 3M employees, revealing that production employees had the highest serum levels of PFOS (0.628 ppm), PFOA (3.6 ppm), and PFHS (0.117 ppm), while management and office employees had significantly lower levels.
|
— |
AR226-0033
|
dYo70Jp13zYyDbmZBbozdBwvR |
16 |
|
This document outlines a pharmacokinetic study protocol by 3M to assess the oral absorption, clearance, and biological persistence of Perfluorooctane Sulfonamide (PFOSA) in rats, aiming to investigate its potential conversion to PFOS and improve risk characterization.
|
— |
AR226-0664
|
gLbd8M1d9G1EDgBMz7gx3YyG |
333 |
|
This document is the third edition of the "Guide to the Safe Handling of Fluoropolymer" published by the Fluoropolymers Division of The Society of the Plastics Industry, Inc., which outlines safety measures, emergency response procedures, and regulatory information related to fluoropolymer resins.
|
— |
AR226-1064
|
wrX2mZvXXwQjdrGa4Q7Bzej64 |
111 |
|
This is a TSCA NCIC Notification Form regarding confidential business information (CBI) related to a document claimed under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1071
|
dxvL97y444dzBVnXb9VxBqYR |
1 |
|
This document reports on the ongoing photodegradation testing of perfluorooctanesulfonate (PFOS), indicating that after 30 days of simulated sunlight exposure in distilled water, there was no degradation observed.
|
— |
AR226-0056
|
wgw4m7baNBBEkDQ38j95dp5dB |
17 |
|
The document discusses biodegradation studies of perfluorooctanesulfonate (PFOS), indicating that it is persistent and that no biodegradation was observed in two conducted studies, while new testing is being initiated to explore potential biological degradation mechanisms.
|
— |
AR226-0057
|
k6MXkXJ2px7vx4aDZNDxqy8O |
32 |
|
This analytical report from Centre Analytical Laboratories details the fluorochemical characterization of drinking water samples from Columbus, GA, specifically analyzing for perfluorooctane sulfonate (PFOS), perfluorooctane sulfonamide (PFOSA), and perfluorooctanoate (POAA) using liquid chromatography/tandem mass spectrometry (LC/MS/MS).
|
— |
AR226-0065
|
g2dokY5JQ1rornGqybXpNmYz9 |
8 |
|
This document outlines a method for the determination of Perfluorooctane sulfonate (PFOS), Perfluorooctane Sulfonylamide (PFOSA), and Perfluorooctanoate (POAA) in water samples using liquid-solid extraction and high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS/MS).
|
— |
AR226-0064
|
p2Qna75L7N2zOz1nrjLXo3rD |
17 |
|
This document is an analytical report from Centre Analytical Laboratories detailing the fluorochemical characterization of drinking water samples from Pensacola, FL, specifically analyzing for perfluorooctane sulfonate (PFOS), perfluorooctane sulfonamide (PFOSA), and perfluorooctanoate (POAA) using liquid chromatography/tandem mass spectrometry (LC/MS/MS).
|
— |
AR226-0066
|
b47vVKvyqx3Q3kLK089dpNeO |
8 |
|
This document is an analytical report from Centre Analytical Laboratories detailing the fluorochemical characterization of drinking water samples from Port St. Lucie, FL, specifically analyzing for perfluorooctane sulfonate (PFOS), perfluorooctane sulfonamide (PFOSA), and perfluorooctanoate (POAA) using liquid chromatography/tandem mass spectrometry (LC
|
— |
AR226-0067
|
nkJeokonyVJbJ9bOXJ2gKVMXw |
8 |
|
The document is an analytical report from Centre Analytical Laboratories detailing the fluorochemical characterization of drinking water samples from Mobile, Alabama, specifically analyzing for perfluorooctane sulfonate (PFOS), perfluorooctane sulfonamide (PFOSA), and perfluorooctanoate (POAA) using LC/MS/MS methods.
|
— |
AR226-0069
|
pmb6zZZLNNGxapQ5bjjpN2RDX |
8 |
|
The laboratory report from 3M details the LCMSMS analysis of extracts from environmental samples, specifically detecting low levels of PFOS in fish samples, which were approximately half of the levels reported in a previous study by P. Jones and K. Kannan, likely due to matrix interference.
|
— |
AR226-0078
|
byJdmzK2JVOJ3pNo4Q84KBbLZ |
6 |
|
The document reports on the analysis of liver samples from various bird species for the presence of PFOS and PFOSA, conducted by 3M Environmental Laboratory, revealing the presence of these fluorochemicals in the samples collected from multiple states across the U.S.
|
— |
AR226-0079
|
QbNe03qKDn800ggdzbBNRGQR |
10 |
|
The document reports on the analysis of PFOS levels in sera samples from juvenile bald eagles and Layson albatrosses, finding PFOS concentrations of 30-77 ppb in eagle samples while no detectable levels were found in albatross samples.
|
— |
AR226-0080
|
zzX7rwBr6ZM51k1mpMXYk1Bv6 |
6 |